CardioMech AS — Form D
CardioMech AS of Trondheim, Q8, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-20. The offering totals $12.7M, of which $12.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-20
- Form: D
- Accession: 0001042167-23-000072
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.7M
- Amount sold: $12.7M
- Minimum investment: $5K
- Investors: 100
- Date of first sale: 2023-12-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-500317
Issuer
- Name: CardioMech AS
- CIK: 0001768128
- Entity type: Other
- Jurisdiction: NORWAY
- Address: Udbyes Gate 3a, Trondheim, Q8, 7030
- Phone: 4721546100
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Jacob Bergsland | Director | N?rsnes, Q8 |
| Richard Nehm | Director | Alingsas, V7 |
| Richard Nehm | Executive Officer | Alingsas, V7 |
| Florian Eckhardt | Director | Trondheim, Q8 |
| Jan Habrekke | Director | Trondheim, Q8 |
| Vic, Jr. Bertrand | Director | Trondheim, Q8 |
| Mark Novotny | Director | San Antonio, TX |
| Jacob Bergsland | Executive Officer | N?rsnes, Q8 |
| Vic Bertrand, Jr. | Director | Beaconsfield, A8 |
| Jacob Justin Gabriel Bergsland | Director | Dr?bak, Q8 |
| Jacob Justin Gabriel Bergsland | Executive Officer | Dr?bak, Q8 |
| Frederik Justin Gabriel Groenewegen | Director | Munich, 2M |
| Vic Joseph Bertrand | Director | Beaconsfield, A8 |
| Nikolai Hiorth | Executive Officer | Oslo, Q8 |
Other filings by this issuer (6)
More